STOCK EXCHANGE INTIMATION 2025-2026
Intimation of Board Meeting-
- Intimation of Board Meeting dated 12th January 2026
- Intimation of Board Meeting dated 13th October 2025
- Intimation of Board Meeting dated 22nd July 2025
- Intimation of Board Meeting dated 20th May 2025
Outcome of Board Meeting
- Outcome of Board Meeting dated 16th January 2026
- Outcome of Board Meeting dated 17th October 2025
- Outcome of Board Meeting dated 28th July 2025
- Outcome of Board Meeting dated 26th May 2025
- Outcome of the Board Meeting held on April 10, 2025
Financial Results
- Financial Results-31st December 2025
- Financial Results- 30th September 2025
- Financial Results- 30th June 2025
- Financial Results- 31st March 2025
Newspaper Publication for Results
- Newspaper Publication for 31st December 2025 Results
- Newspaper Publication for 30th September Results
- Newspaper publication for 30th June 2025 Results
- Newspaper Publication for 31st March 2025 Results
General Updates Under Regulation 30 of SEBI (LODR) Regulations, 2015
- Disclosure under Regulation 30(5) of the SEBI (LODR) Regulations, 2015
- Earning updates for the quarter ended 31st December 2025
- Intimation for appointment of Mr. Umeshkumar L Bhavsar as an Additional Director (Non-Executive Independent Director Category)
- Intimation for appointment of Mrs. PD Amin as an Additional Director (Non-Executive Independent Director Category)
- Intimation for approval from CDSCO for Phase III Clinical Trial and Bioequivalence Study of Suvorexant Tablets
- Intimation for Investor Presentation
- Intimation for Order received from Hon’ble High Court, Gujarat
- Intimation of schedule of Analyst/ Institutional Investor Meetings under the SEBI (LODR) Regulations, 2015
- Intimation for appointment of Mr. Shreekumar Shankarnarayan Nair as Chief Operating Officer of the Company
- Intimation for appointment of Mr. PD Vaghela as an Additional Director (Non-Executive Independent Director Category)
- Earning updates for the Quarter ended 30th September 2025
- Intimation for Grant of Employee Stock Options under “Bajaj Healthcare Limited Employee Stock Option Plan 2024”
- The Company has received recommendation from Subject Expert Committee (SEC) (Neurology & Psychiatry)of CDSCO to conduct Phase III clinical trials for Suvorexant Tablets
- Intimation for resignation of Mr. Yaqoob Ali as a Non-Executive Independent Director
- Intimation of newspaper advertisement pursuant to Launch of 100 Days Campaign-“Saksham Niveshak”
- Intimation for appointment of Mr. Sandeep Shah as an Additional Director (Non-Executive Non-Independent Director Category)
- Intimation for appointment of Mr. Gopalakrishnan Kesavan as an Additional Director (Non-Executive Independent Director Category)
- Earning Updates for the Quarter ended 30th June 2025
- Intimation for re-appointment of Ms. Kejal Niken Shah as a Non-Executive Independent Director
- Resignation of Mr. Dhananjay Sabaji Hatle as Whole-Time Director of the Company
- Resignation of Mr. Sandeep Shah as an Independent Director
- Earning Updates for the quarter & year ended 31st March 2025
- Credit Rating
- Intimation for Grant of Employee Stock Options under “Bajaj Healthcare Limited Employee Stock Option Plan 2024”
- Press Release for acquisition of Corporate Debtor, Genrx Pharmaceuticals Private Limited (in Liquidation) as going concern
- Intimation for acquisition of Corporate Debtor, Genrx Pharmaceuticals Private Limited (in Liquidation) as going concern
Trading Window Closure
- Intimation for closure of Trading Window for the Quarter ended December 31, 2025
- Intimation for closure of Trading Window for the Quarter ended September 30, 2025
- Intimation for Closure of Trading Window for the Quarter ended June 30, 2025
Shareholding pattern
- Shareholding Pattern for the quarter ended 31st December 2025
- Shareholding Pattern for the Quarter ended 30th September 2025
- Shareholding Pattern for the period ended 30th June 2025
32nd Annual General Meeting
- Unclaimed Dividend
- Intimation for Voting Results & Scrutinizer’s Report
- Outcome of the 32nd AGM
- Intimation of Record Date for the purpose of Final Dividend
- Intimation for Newspaper Advertisement (Post-Dispatch)
- BRSR FY 2025
- Annual return FY 2025
- Intimation for Letter sent to SH
- Intimation for BRSR FY 2025
- Intimation for Annual Report FY 2025
- Intimation for Notice of 32nd AGM
- Annual Report
- Intimation for Newspaper Advertisement (Pre-Dispatch)
Monitoring Agency Report
Integrated Filing (Financial)
- Integrated Filing for the quarter & nine months ended 31st December 2025
- Integrated Filing for the quarter & half year ended 30th September 2025
- Integrated Filing for the Quarter ended 30th June 2025
Integrated Filing (Governance)
- Integrated Filing for the quarter ended 31st December 2025
- Integrated Filing for the Quarter ended 30th September 2025
- Integrated Filing for the period ended 30th June 2025
Annual Secretarial Compliance Report
Compliance Certificate
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 31st December 2025
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended 30th September 2025
- Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the Quarter ended June 2025
Reconciliation of Share Capital Audit Report
- Reconciliation of Share Capital Audit Report December 2025
- Reconciliation of Share Capital Audit Report September 2025
- Reconciliation of Share Capital Audit Report June 2025
Postal Ballot
- Intimation for Voting Results & Scrutinizer’s Report
- Newspaper publication for dispatch of Notice of Postal Ballot
- Intimation for Notice of Postal Ballot
- Notice of Postal Ballot
Familiarization Programme
Statement of Deviation & Variation